Joanna Pepke-Zaba Selected Research

Endarterectomy (Thromboendarterectomy)

7/2021	Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry.
1/2021	ERS statement on chronic thromboembolic pulmonary hypertension.
1/2021	Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension.
10/2020	CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
1/2019	The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
11/2018	Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
1/2018	The outcome of reoperative pulmonary endarterectomy surgery.
1/2018	The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
5/2016	Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.
1/2016	Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Pepke-Zaba Research Topics

Disease

54	Pulmonary Hypertension 01/2022 - 06/2004
35	Pulmonary Arterial Hypertension 01/2022 - 02/2002
10	Familial Primary Pulmonary Hypertension 12/2021 - 02/2011
3	Hemorrhage 01/2021 - 03/2011
2	Pulmonary Embolism 01/2021 - 01/2019
2	Hemoptysis 01/2021 - 12/2020
2	Anemia 01/2021 - 01/2013
2	Iron Deficiencies 01/2021 - 01/2013
2	Lung Diseases (Lung Disease) 01/2020 - 06/2004
2	Inflammation (Inflammations) 01/2019 - 08/2010
2	Heart Failure 03/2016 - 04/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2016 - 06/2004
2	Clinical Deterioration 08/2013 - 04/2011
1	Body Weight (Weight, Body) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Fibrosis (Cirrhosis) 06/2020
1	Liver Diseases (Liver Disease) 06/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Channelopathies 10/2018
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2017
1	Lymphadenopathy 11/2017
1	Rare Diseases (Rare Disease) 11/2017
1	Hypertension (High Blood Pressure) 07/2017
1	Coronary Disease (Coronary Heart Disease) 03/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Disease Progression 12/2014
1	Cardiomyopathies (Cardiomyopathy) 09/2014
1	Right Ventricular Dysfunction 02/2014
1	Thrombosis (Thrombus) 01/2014
1	Hypoxia (Hypoxemia) 08/2012
1	Vascular Remodeling 08/2012
1	Venous Thromboembolism 11/2011
1	Vasculitis (Vasculitides) 07/2011

Drug/Important Bio-Agent (IBA)

6	riociguatIBA 01/2022 - 05/2014
5	CamphorIBA 10/2021 - 08/2013
5	Sildenafil Citrate (Viagra)FDA Link 06/2010 - 06/2004
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 11/2007
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
4	Soluble Guanylyl CyclaseIBA 01/2021 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2010
3	IronIBA 01/2021 - 04/2011
3	Bosentan (Tracleer)FDA Link 12/2008 - 06/2006
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 11/2018
2	CytokinesIBA 01/2022 - 08/2010
2	ferric carboxymaltoseIBA 01/2021 - 01/2013
2	Carbon MonoxideIBA 01/2020 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 10/2016
2	Clostridium perfringens epsilon-toxinIBA 03/2014 - 01/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011 - 06/2004
2	Iloprost (Ventavis)FDA Link 02/2011 - 09/2006
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2011 - 09/2006
2	Endothelin Receptor AntagonistsIBA 12/2008 - 09/2006
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2008 - 09/2006
1	ProteomeIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Vitamin K FDA Link 01/2022
1	N(4)-oleylcytosine arabinosideIBA 01/2022
1	Biological ProductsIBA 12/2021
1	Transferrin (beta 2 Transferrin)IBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	hydralazine 4-anisaldehyde hydrazoneIBA 01/2021
1	LigandsIBA 06/2020
1	EndoglinIBA 06/2020
1	Natriuretic PeptidesIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	AntigensIBA 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	N 30IBA 01/2019
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	PotassiumIBA 10/2018
1	Calcium Channels (Calcium Channel)IBA 12/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2017
1	Prokaryotic Initiation Factor-2IBA 11/2017
1	Peroxidase (Myeloperoxidase)IBA 10/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2016
1	Endothelins (Endothelin)IBA 08/2016
1	Endothelin-1 (Endothelin 1)IBA 08/2016
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 10/2015
1	LipopolysaccharidesIBA 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2015
1	HepcidinsIBA 01/2013
1	InterferonsIBA 08/2012
1	MonocrotalineIBA 08/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2012
1	OsteoprotegerinIBA 01/2012

Therapy/Procedure

29	Therapeutics 07/2021 - 06/2004
26	Endarterectomy (Thromboendarterectomy) 07/2021 - 06/2004
5	Catheters 04/2017 - 12/2013
2	Transplantation 04/2011 - 06/2004
1	Perioperative Period 05/2016
1	Aftercare (After-Treatment) 01/2016
1	Radiofrequency Ablation 01/2015
1	Extracorporeal Membrane Oxygenation 03/2011